Surgical Science EBITDA vs. Earnings Per Share
| SUS Stock | SEK 146.10 4.10 2.89% |
For Surgical Science profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Surgical Science to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Surgical Science Sweden utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Surgical Science's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Surgical Science Sweden over time as well as its relative position and ranking within its peers.
Surgical |
Surgical Science Sweden Earnings Per Share vs. EBITDA Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Surgical Science's current stock value. Our valuation model uses many indicators to compare Surgical Science value to that of its competitors to determine the firm's financial worth. Surgical Science Sweden is currently regarded as top stock in ebitda category among its peers. It also is currently regarded as top stock in earnings per share category among its peers . The ratio of EBITDA to Earnings Per Share for Surgical Science Sweden is about 46,138,868 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Surgical Science's earnings, one of the primary drivers of an investment's value.Surgical Earnings Per Share vs. EBITDA
EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.
Surgical Science |
| = | 122.27 M |
In a nutshell, EBITDA is calculated by adding back each of the excluded items to the post-tax profit, and can be used to compare companies with very different capital structures.
Earnings per Share (EPS) denotes the portion of a company's earnings that is allocated to each share of common stock. To calculate Earnings per Share investors will need to take a company's net income, subtract any dividends for preferred stock, and divide it by the number of average outstanding shares. EPS is usually presented in two different ways: basic and diluted. Fully diluted Earnings per Share takes into account effects of warrants, options, and convertible securities and is generally viewed by analysts as a more accurate measure.
Surgical Science |
| = | 2.65 X |
Earnings per Share is one of the most critical measures of the firm's current share price and is used by investors to determine the overall company profitability, especially when compared to the EPS of similar companies.
Surgical Earnings Per Share Comparison
Surgical Science is currently under evaluation in earnings per share category among its peers.
Surgical Science Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in Surgical Science, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Surgical Science will eventually generate negative long term returns. The profitability progress is the general direction of Surgical Science's change in net profit over the period of time. It can combine multiple indicators of Surgical Science, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Surgical Science Sweden AB develops and markets virtual reality simulators for evidence based laparoscopic and endoscopic training. Surgical Science AB was founded in 1999 and is headquartered in Gothenburg, Sweden. Surgical Science is traded on Stockholm Stock Exchange in Sweden.
Surgical Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Surgical Science. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Surgical Science position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Surgical Science's important profitability drivers and their relationship over time.
Use Surgical Science in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Surgical Science position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Surgical Science will appreciate offsetting losses from the drop in the long position's value.Surgical Science Pair Trading
Surgical Science Sweden Pair Trading Analysis
The ability to find closely correlated positions to Surgical Science could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Surgical Science when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Surgical Science - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Surgical Science Sweden to buy it.
The correlation of Surgical Science is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Surgical Science moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Surgical Science Sweden moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Surgical Science can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your Surgical Science position
In addition to having Surgical Science in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Gambling Thematic Idea Now
Gambling
Companies that are related to providing gambling services across multiple geographical areas by investing, exploring, or producing software, hardware, and related infrastructure for running gambling operations or trading speculative assets. The Gambling theme has 38 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Gambling Theme or any other thematic opportunities.
| View All Next | Launch |
Additional Tools for Surgical Stock Analysis
When running Surgical Science's price analysis, check to measure Surgical Science's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Surgical Science is operating at the current time. Most of Surgical Science's value examination focuses on studying past and present price action to predict the probability of Surgical Science's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Surgical Science's price. Additionally, you may evaluate how the addition of Surgical Science to your portfolios can decrease your overall portfolio volatility.